YGT-11456-33396
3 vaccinations
2 coded responses
6 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 338 / FL
- Registered
- 2021-08-25
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-04
Dose 1 — Pfizer-BioNTech
-
2021-08-25
Registered in v-safe
-
2021-08-25
Dose 2 — Pfizer-BioNTech
-
2021-08-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-08-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-09-15
-
2021-11-26
Survey response — 3 months, dose 2MedDRA: Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Extremely bad nauseaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-26
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-29
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-20
Dose 3 — Pfizer-BioNTech
-
2022-05-11
Survey response — day 21, dose 3MedDRA: Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-04 | Pfizer-BioNTech | No |
| 2 | 2021-08-25 | Pfizer-BioNTech | No |
| 3 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-26 | Successful 2021-11-29 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — 3 months, dose 2
Symptoms: Extremely bad nausea
Release 11 — day 21, dose 3
Symptoms: Nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release